Watch this recorded webinar to learn about the regulatory frameworks for regenerative medicine in Japan, as well as opportunities for collaboration with the Forum for Innovative Regenerative Medicine (FIRM).
Japan is a world leading country in the research field of regenerative medicine.
In November 2014, the regenerative medicine safety law came into force and has built momentum for practical medicine under the Pharmaceutical and Medical Device Affairs Law in Japan. The new legal framework is expected to provide an impetus to the commercialisation of regenerative medicine products in Japan.
The Forum for Innovative Regenerative Medicine (FIRM) is a business community organisation in Japan – with over 100 member corporations – that has been playing a vital role in working with other industry groups, government and universities to promote regenerative medicine as a new medicine and a new industrial field, as well as ensuring that research results are quickly commercialised in a safely and timely manner.